TPCN2
protein-codingtwo pore segment channel 2, the group of Two pore segment channels|MicroRNA protein coding host genes
Gene summary
This gene encodes a putative cation-selective ion channel with two repeats of a six-transmembrane-domain. The protein localizes to lysosomal membranes and enables nicotinic acid adenine dinucleotide phosphate (NAADP) -induced calcium ion release from lysosome-related stores. This ubiquitously expressed gene has elevated expression in liver and kidney. Two common nonsynonymous SNPs in this gene strongly associate with blond versus brown hair pigmentation.[provided by RefSeq, Dec 2009]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~87.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0043209
Submitter: Ambry Genetics
Clinical Genomic Database (CGD)
Manifestation: Dermatologic
Intervention: General
Rationale: The condition may not be clinically relevant
Comments: Variants may be involved in sun sensitivity
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TPCN2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_139075.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 8 | 4 | 16 | ||
| missense | 1 | 135 | 7 | 3 | 146 | |
| nonsense | 0 | |||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 9 | 9 | ||||
| Total | 0 | 1 | 148 | 15 | 7 | 171 |
Highest pathogenic variant AF is 0.0000024784345
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_620714.2 | 25 | MANE Select | |
| Ensembl | ENSP00000294309.3 | 25 | MANE Select | |
| Ensembl | ENSP00000445551.1 | 18 | Standard | |
| Ensembl | ENSP00000445551.1 | 18 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| tpcn2 | Danio rerio | Structure: slow muscle cell Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Pancreatic secretion - Homo sapiens (human)
- VEGFA-VEGFR2 Signaling Pathway
- Ebola Virus Pathway on Host
- Ebola Virus Pathway on Host
- Stimuli-sensing channels
Biological Process
- cellular calcium ion homeostasis
- smooth muscle contraction
- lysosome organization
- regulation of autophagy
- calcium-mediated signaling
Molecular Function
- voltage-gated calcium channel activity
- protein binding
- protein kinase binding
- identical protein binding
- NAADP-sensitive calcium-release channel activity
Cellular Component
- lysosome
- lysosomal membrane
- endosome membrane
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000294309
- Coding exons
- 25
- Length
- 41708
- Individuals with no LoFs
- 125659
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 89
- Defined
- 125748
- p
- 0.000354
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.451 | 412 | 439 | 0.939 | 0.0000278 | 4827 |
| Missense (PolyPhen) | 151 | 180.17 | 0.83812 | 1886 | ||
| Synonymous | 0.349 | 185 | 191 | 0.968 | 0.0000126 | 1528 |
| Loss of Function | 3.30 | 24 | 48.9 | 0.491 | 0.00000265 | 492 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00056 | 0.00055 | rare |
| Latino/Admixed American | 0.00049 | 0.00049 | rare |
| Ashkenazi Jewish | 0.00011 | 0.000099 | rare |
| East Asian | 0.00038 | 0.00038 | rare |
| Finnish | 0.00028 | 0.00028 | rare |
| European (Non-Finnish) | 0.00038 | 0.00036 | rare |
| South Asian | 0.00026 | 0.00026 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Nicotinic acid adenine dinucleotide phosphate (NAADP) receptor that may function as one of the major voltage-gated Ca(2+) channels (VDCC) across the lysosomal membrane. May be involved in smooth muscle contraction. {ECO:0000269|PubMed:19387438, ECO:0000269|PubMed:19620632}.;
Recessive Scores
- pRec
- 0.130
Intolerance Scores
- LoFtool
- 0.0941
- RVIS EVS
- -0.34
- RVIS percentile EVS
- 29.62
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.170
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |